Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabian Fehlauer

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
Defining the optimal dose of radiation after incomplete resection of central neurocytomasDirk Rades, Steven E Schild, Kiyonobu Ikezaki, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 23, 2003
[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]Dirk Rades, Fabian Fehlauer, Steven Schild, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2004
Serious adverse effects of amifostine during radiotherapy in head and neck cancer patientsDirk Rades, Fabian Fehlauer, Amira Bajrovic, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scoresUlrike Hoeller, Silke Tribius, Antje Kuhlmey, et al.
Oral Oncology|September 29, 2006
Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapyDirk Rades, Fabian Fehlauer, Junes Wroblesky, et al.
Journal of Neuro-Oncology|November 6, 2004
Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center studyDirk Rades, Fabian Fehlauer, Axel Hartmann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring systemFabian Fehlauer, Silke Tribius, Ulrike Höller, et al.
Neuro-Oncology|February 11, 2005
Well-differentiated neurocytoma: what is the best available treatment?Dirk Rades, Fabian Fehlauer, Katrin Lamszus, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 6, 2003
Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?Peter Vacha, Fabian Fehlauer, Birgit Mahlmann, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Cosmesis from the patient's and the doctor's viewUlrike Hoeller, Antje Kuhlmey, Amira Bajrovic, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
Defining the optimal dose of radiation after incomplete resection of central neurocytomasDirk Rades, Steven E Schild, Kiyonobu Ikezaki, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 23, 2003
[Treatment for central neurocytoma: a meta-analysis based on the data of 358 patients]Dirk Rades, Fabian Fehlauer, Steven Schild, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 6, 2004
Serious adverse effects of amifostine during radiotherapy in head and neck cancer patientsDirk Rades, Fabian Fehlauer, Amira Bajrovic, et al.
International Journal of Radiation Oncology, Biology, Physics|February 28, 2003
Increasing the rate of late toxicity by changing the score? A comparison of RTOG/EORTC and LENT/SOMA scoresUlrike Hoeller, Silke Tribius, Antje Kuhlmey, et al.
Oral Oncology|September 29, 2006
Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapyDirk Rades, Fabian Fehlauer, Junes Wroblesky, et al.
Journal of Neuro-Oncology|November 6, 2004
Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center studyDirk Rades, Fabian Fehlauer, Axel Hartmann, et al.
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Long-term radiation sequelae after breast-conserving therapy in women with early-stage breast cancer: an observational study using the LENT-SOMA scoring systemFabian Fehlauer, Silke Tribius, Ulrike Höller, et al.
Neuro-Oncology|February 11, 2005
Well-differentiated neurocytoma: what is the best available treatment?Dirk Rades, Fabian Fehlauer, Katrin Lamszus, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 6, 2003
Randomized phase III trial of postoperative radiochemotherapy +/- amifostine in head and neck cancer. Is there evidence for radioprotection?Peter Vacha, Fabian Fehlauer, Birgit Mahlmann, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Cosmesis from the patient's and the doctor's viewUlrike Hoeller, Antje Kuhlmey, Amira Bajrovic, et al.
Pageof 3